Last reviewed · How we verify
placebo tablets and questionaires — Competitive Intelligence Brief
phase 3
Psychiatry
Small molecule
Live · refreshed every 30 min
Target snapshot
placebo tablets and questionaires (placebo tablets and questionaires) — Memorial Sloan Kettering Cancer Center. This drug is a placebo, having no active pharmacological mechanism.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| placebo tablets and questionaires TARGET | placebo tablets and questionaires | Memorial Sloan Kettering Cancer Center | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- placebo tablets and questionaires CI watch — RSS
- placebo tablets and questionaires CI watch — Atom
- placebo tablets and questionaires CI watch — JSON
- placebo tablets and questionaires alone — RSS
Cite this brief
Drug Landscape (2026). placebo tablets and questionaires — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-tablets-and-questionaires. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab